Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2007
09/19/2007EP1833991A2 Trefoil factors and methods of treating proliferation disorders using same
09/19/2007EP1833850A1 Framework residue substituted humanized col-1 antibodies and their use
09/19/2007EP1833840A2 Potent lna oligonucleotides for the inhibition of hif-1a
09/19/2007EP1833836A1 Imidazo-fused thiazolo [4,5-b] pyridine based tricyclic compounds and pharmaceutical compositions comprising same
09/19/2007EP1833832A1 Napthyridine compounds as rock inhibitors
09/19/2007EP1833830A1 Quinoline derivative, use and production thereof, and drug containing the same
09/19/2007EP1833823A1 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
09/19/2007EP1833820A1 Selective inhibitors of erk protein kinase and uses therof
09/19/2007EP1833819A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
09/19/2007EP1833807A1 Ubiquitin ligase inhibitors
09/19/2007EP1833803A2 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
09/19/2007EP1833511A2 Method of treating brain cancer
09/19/2007EP1833506A2 Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
09/19/2007EP1833501A1 Laminin receptor binding molecule
09/19/2007EP1833481A1 Farnesyl protein transferase inhibitors and methods for treating proliferative diseases
09/19/2007EP1684702B1 Use of 2-thia-dibenzo[e,h]azulenes for the treatment and prevention of central nervous system diseases and disorders
09/19/2007EP1682131B1 Cci-779 for treating mantle cell lymphoma
09/19/2007EP1673338B1 Fatty acid compounds, preparation and uses thereof
09/19/2007EP1572066A4 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
09/19/2007EP1567522B1 Pyrimidine compounds
09/19/2007EP1565196B1 Preparing method of dendritic cell for cancer immunotherapy
09/19/2007EP1539768B1 A new process for the preparation of epothilone derivatives
09/19/2007EP1515975B1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/19/2007EP1499605B1 NF-KappaB INHIBITORS
09/19/2007EP1496907B1 Tyrosine kinase inhibitors
09/19/2007EP1478773B1 Methods for assessing acute myeloid leukemia
09/19/2007EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
09/19/2007EP1408911B1 Sustained-release therapeutic bioadhesive systems
09/19/2007EP1407044B1 Rna interference mediating small rna molecules
09/19/2007EP1326990B1 Packaging of positive-strand rna virus replicon particles
09/19/2007EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
09/19/2007EP1263803B1 Embolic compositions
09/19/2007EP1242110B1 Composition for treating prostate cancer
09/19/2007EP1190071B1 17867, a novel human aminopeptidase
09/19/2007EP1141003B1 Methods of activation of SGK by phosphorylation.
09/19/2007CN101039952A Analogs of 17-hydroxywortmannin as pi3k inhibitors
09/19/2007CN101039946A Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
09/19/2007CN101039944A 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity
09/19/2007CN101039943A Novel azaindole thiazolinones as anti-cancer agents
09/19/2007CN101039939A Quinazolinylmethylene thiazolinones as cdk1 inhibitors
09/19/2007CN101039936A Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
09/19/2007CN101039932A Heterocyclic substituted bisarylurea derivatives as kinase inhibitors
09/19/2007CN101039925A Benzoxazepine derivatives as selective estrogen receptor modulators
09/19/2007CN101039919A N-benzenesulfonyl substituted anilino-pyrimidine analogs
09/19/2007CN101039918A Small molecule modulators of cytokine activity
09/19/2007CN101039914A Trifluoromethyl substituted benzamide as kinase inhibitors
09/19/2007CN101039681A Intestinal polyp inhibitor
09/19/2007CN101039676A Dihydropteridinone infusion solution having a long shelf life
09/19/2007CN101039663A STAT3 phosphorylation inhibitor and notch 1 expression inhibitor
09/19/2007CN101039660A Stable pegylated interferon formulation
09/19/2007CN101037691A CENP-E combined protein and encoding gene and application
09/19/2007CN101037689A Anti-sense nucleotide of c-erbB2 cancer gene combined with epidermal growth factor and its application
09/19/2007CN101037688A Small molecule interfering RNA and its anti-tumor use
09/19/2007CN101037678A Preparation of decorative yak blood source SOD and decorative yak blood source SOD anticancer health food by yak blood
09/19/2007CN101037670A Effecter cell for preventing and curing CEA positive tumor and preparation method and application thereof
09/19/2007CN101037481A Loose knot total polysaccharide and preparation method and usage thereof
09/19/2007CN101037478A Rebuild golden staphylococcus enterotoxin N and preparation and application thereof
09/19/2007CN101037475A Chimerical receptor and preparation method and usage
09/19/2007CN101037473A R. grahami rnmunoregulating polypeptide, gene and variant and its application in medicine production
09/19/2007CN101037469A Method for extracting small molecule active peptides from scapharca subcrenata
09/19/2007CN101037468A Preparation method of oyster active peptides
09/19/2007CN101037437A Flazin analog and preparation method and application thereof
09/19/2007CN101037428A Purification of sesquiterpene lactones A in achillea alpine and anti-tumour cell proliferative activity thereof
09/19/2007CN101037423A High spermidine conjugates, preparation and application thereof
09/19/2007CN101037391A Natural polyamines derivatives, preparation and application thereof
09/19/2007CN101036789A RNA-interfering medicine of antineoplastic targeting focal adhesion kinase FAK
09/19/2007CN101036788A Pulullan polysaccharide carrier material having the function of targeting therapy of cancer and the preparation method
09/19/2007CN101036774A Quality control method of compound cantharidin oral preparations
09/19/2007CN101036761A Process for preparing coix seed oil
09/19/2007CN101036741A Medicine for treating cancer and preparing method therefor
09/19/2007CN101036732A Chinese medicine preparation for esophagus cancer and its compounding process
09/19/2007CN101036730A Selenium germanium peptide jujube tea powder for curing cancer radically
09/19/2007CN101036729A Biological selenium germanium peptide maggot jujube tea powder for preventing SARS
09/19/2007CN101036727A Selenium germanium peptide jujube tea powder for preventing avian influenza
09/19/2007CN101036698A Mulberry leaf extract and its preparing process and application
09/19/2007CN101036685A Microemulsion injection including tubeimoside
09/19/2007CN101036675A Method for extracting flavonoids from the waxberry core
09/19/2007CN101036674A Injection including polysaccharides from ginkgo biloba
09/19/2007CN101036665A Injection containing flammulina velutipes
09/19/2007CN101036652A Use of 4-pyridylmethylphthalazines for cancer treatment
09/19/2007CN101036644A Pharmaceutical composition containing arctigenin and preparation method
09/19/2007CN101036643A Pharmaceutical composition containing arctigenin and preparation method
09/19/2007CN101036638A Application of glycyrrhizin in the preparation of medicine for preventing and curing tumour
09/19/2007CN101036637A Application of salvia miltiorrhiza bge I sodium sulfonate in the preparation of medicine and its medicine made by the same
09/19/2007CN100338219C Tissue specific expression of retinoblastoma protein
09/19/2007CN100338086C Immunostimulatory nucleic acid molecules
09/19/2007CN100338077C Combretastatin A-4 phosphate prodrug, mono-and di-organic amine salt, mono-and di-amino acids salts, and mono-and di-amino acid ester salt
09/19/2007CN100338071C New benzo-oxazino-isoindole derivatives, useful for treating cancers, are inhibitors of the cell cycle
09/19/2007CN100338066C Hexacyclic compounds
09/19/2007CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases
09/19/2007CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors
09/19/2007CN100338042C Triazole derivatives as cyclooxygenase (COX) inhibitors
09/19/2007CN100338041C Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
09/19/2007CN100338036C Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes
09/19/2007CN100337684C Thymic pentapeptide aqua prepn and its prepn process and application
09/19/2007CN100337674C Medicine for treating hysteromyoma and its preparation method
09/19/2007CN100337652C Chinese medicinal decoction for preventing and treating cancer
09/19/2007CN100337635C Medicine containing general pasqueflower saponin composition and its preparation method and uses
09/19/2007CN100337631C Fluorouracil injecting emulsion and production thereof
09/19/2007CN100337625C Anastrozole dispersed tablet formulation
1 ... 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 ... 2211